Adjuvant S-1 Chemotherapy for Gastric Cancer and Peritoneal Wash

被引:0
作者
Seiji Ito
机构
[1] Aichi Cancer Center,Department of Gastroenterological Surgery
来源
World Journal of Surgery | 2011年 / 35卷
关键词
Gastric Cancer; Trastuzumab; Gastric Cancer Patient; Peritoneal Carcinomatosis; Stomach Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:470 / 471
页数:1
相关论文
共 18 条
[1]  
Sakuramoto S(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-1820
[2]  
Sasako M(1999)Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group Lancet 354 273-277
[3]  
Yamaguchi T(2003)Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1 J Clin Oncol 21 2282-2287
[4]  
Nakajima T(2008)D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer N Engl J Med 359 453-462
[5]  
Nashimoto A(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
[6]  
Kitamura M(2010)Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis Ann Oncol 21 67-70
[7]  
Nashimoto A(undefined)undefined undefined undefined undefined-undefined
[8]  
Nakajima T(undefined)undefined undefined undefined undefined-undefined
[9]  
Furukawa H(undefined)undefined undefined undefined undefined-undefined
[10]  
Sasako M(undefined)undefined undefined undefined undefined-undefined